New Drug Approvals

BRIVARACETAM March 23, 2016 - (0)

BRIVARACETAM, UCB-34714 (2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide (2S)-2-[(4R)-2-Oxo-4-propyl-1-pyrrolidinyl]butanamide 1-Pyrrolidineacetamide, α-ethyl-2-oxo-4-propyl-, (αS,4R)- CAS 357336-20-0 Molecular Formula: C11H20N2O2 Molecular Weight: 212.2887 g/mol UNII-U863JGG2IA UCB; For the treatment of partial onset seizures related to epilepsy, Approved February 2016 Brivaracetam, the 4-n-propyl analog of levetiracetam, is a racetam derivative with anticonvulsant properties.[1][2] Brivaracetam is believed to act by binding to the ubiquitous synaptic vesicle […]
PF-06747775 (Pfizer) Third generation covalent EGFR inhibitors March 23, 2016 - (0)
罗西替尼 роцилетиниб روسيليتينيب Rociletinib, CO-1686. Third generation covalent EGFR inhibitors March 23, 2016 - (0)
EGF 816 , Nazartinib March 23, 2016 - (0)
HELP, Need one time help to pay 10 year concessional subscription to this, your favorite blog to WordPress March 20, 2016 - (3)

Mobile Site | Full Site